Journal of Medicinal Chemistry · 2008 · 103 citations · 29 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryEpigeneticsMolecular PharmacologyCancer EpigeneticsChemical EpigeneticsDna MethylationEnzyme InhibitionNucleic Acid Drug DesignActive Dna DemethylationDna MethyltransferasesHistone DemethylationLead Compound OptimizationNon-nucleoside Inhibitors
Constrained analogues of procaine were synthesized, and their inhibiting activity against DNMT1 was tested. Among them, the most potent compound, derivative 3b, was also able to induce a recognizable demethylation of chromosomal satellite repeats in HL60 human myeloid leukemia cells and thus represents a lead compound for the development of a novel class of non-nucleoside DNMT1 inhibitors.
29
COBRA: a sensitive and quantitative DNA methylation assay
Zhongguo Xiong, Peter W. Laird · Nucleic Acids Research · 1997 · 1.2K citations · Full text